Inspire Investing’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,842
Closed -$1.05M 827
2024
Q4
$1.05M Buy
2,842
+566
+25% +$237K 0.12% 200
2024
Q3
$1.18M Sell
2,276
-1,432
-39% -$765K 0.12% 184
2024
Q2
$2.01M Buy
3,708
+2,856
+335% +$1.51M 0.23% 109
2024
Q1
$442K Sell
852
-92
-10% -$45.8K 0.05% 343
2023
Q4
$445K Buy
944
+107
+13% +$49.5K 0.05% 318
2023
Q3
$364K Sell
837
-53
-6% -$24K 0.05% 335
2023
Q2
$395K Buy
890
+76
+9% +$35.1K 0.05% 326
2023
Q1
$374K Buy
814
+147
+22% +$70K 0.05% 327
2022
Q4
$342K Buy
667
+24
+4% +$12.2K 0.04% 283
2022
Q3
$292K Buy
+643
New +$308K 0.04% 261

Other funds holding ELV

Inspire Investing's ELV Position: Q1 2025 in Review

Inspire Investing sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 2,842 shares — an estimated $1.05M sold.

Inspire Investing first reported a position in ELV in Q3 2022 and held it in 10 quarters. The position peaked at $2.01M in Q2 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Inspire Investing reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Inspire Investing sold 2,842 Elevance Health shares in Q1 2025, an estimated $1.05M.
  • Inspire Investing first reported a position in Elevance Health in Q3 2022 and held it in 10 quarters.
  • Inspire Investing's Elevance Health position peaked at $2.01M in Q2 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Inspire Investing's 13F filing for Q1 2025, filed 3 Jun 2025.